3 Results for "

granzyme A/B/C

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "granzyme A/B/C" in MCE Product Catalog:

Cat. No.: HY-162874
CAS No.: 3035557-60-6
Target:  

STING IFNAR

Research Areas:  

Cancer

diABZI-V/C-DBCO is a STING agonist with an EC50 of 1.47 nM. diABZI-V/C-DBCO activates the STING pathway, induces the production of IFN-I, and stimulates the secretion of IFN-β. diABZI-V/C-DBCO serves as a substrate for cathepsin B, and releases active diABZI-amine via cathepsin B-mediated cleavage. In an orthotopic mouse model of breast cancer, diABZI-V/C-DBCO increases serum IFN-β levels and the frequency of granzyme B + CD8 + T cells. diABZI-V/C-DBCO is applicable to research related to triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-P2922
CAS No.: 9032-68-2
Target:  

Cathepsin

Research Areas:  

Cancer

Cathepsin C is a lysosomal cysteine protease essential for catalytic activation of many serine proteases, including proteinase 3 (PR3), neutrophil elastase (NE), cathepsin G (CTSG), granzyme A/B/C, and mast cell chymase .
loading...
    loading...
Cat. No.: HY-P992021

Research Areas:  

Cancer

WM-A1-3389 is an anti-human IGSF1monoclonal antibody and tumor growth inhibitor. WM-A1-3389 specifically binds to the C-terminus of IGSF1, increases secretion of Granzyme B, IFN?γ, and TNF?α, and inhibits growth of colon cancer or biliary tract cancer in xenogeneic or allogeneic mouse implantation models. WM-A1-3389 can be used for the research of colon cancer, biliary tract cancer, and head and neck cancer .
loading...
    loading...